120 related articles for article (PubMed ID: 30466153)
1. c-Rel is a cell cycle modulator in human melanoma cells.
Priebe MK; Dewert N; Amschler K; Erpenbeck L; Heinzerling L; Schön MP; Seitz CS; Lorenz VN
Exp Dermatol; 2019 Feb; 28(2):121-128. PubMed ID: 30466153
[TBL] [Abstract][Full Text] [Related]
2. c-Rel downregulation affects cell cycle progression of human keratinocytes.
Lorenz VN; Schön MP; Seitz CS
J Invest Dermatol; 2014 Feb; 134(2):415-422. PubMed ID: 23892589
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-365a-3p inhibits c-Rel-mediated NF-κB signaling and the progression of pancreatic cancer.
Yin L; Xiao X; Georgikou C; Yin Y; Liu L; Karakhanova S; Luo Y; Gladkich J; Fellenberg J; Sticht C; Gretz N; Gross W; Herr I
Cancer Lett; 2019 Jun; 452():203-212. PubMed ID: 30910589
[TBL] [Abstract][Full Text] [Related]
4. NOD2 up-regulates TLR2-mediated IL-23p19 expression via NF-κB subunit c-Rel in Paneth cell-like cells.
Tan G; Liang E; Liao K; Deng F; Zhang W; Chen Y; Xu J; Zhi F
Oncotarget; 2016 Sep; 7(39):63651-63660. PubMed ID: 27563808
[TBL] [Abstract][Full Text] [Related]
5. c-Rel deficiency increases caspase-4 expression and leads to ER stress and necrosis in EBV-transformed cells.
Valentín-Acevedo A; Sinquett FL; Covey LR
PLoS One; 2011; 6(10):e25467. PubMed ID: 21984918
[TBL] [Abstract][Full Text] [Related]
6. Suppression of monocyte chemoattractant protein 1, but not IL-8, by alprazolam: effect of alprazolam on c-Rel/p65 and c-Rel/p50 binding to the monocyte chemoattractant protein 1 promoter region.
Oda T; Ueda A; Shimizu N; Handa H; Kasahara T
J Immunol; 2002 Sep; 169(6):3329-35. PubMed ID: 12218154
[TBL] [Abstract][Full Text] [Related]
7. Constitutive expression of c-REL in uveal melanoma patients: correlation with clinicopathological parameters and patient outcome.
Singh MK; Singh L; Pushker N; Chosdol K; Bakhshi S; Meel R; Sen S; Kashyap S
Clin Transl Oncol; 2020 Jul; 22(7):1193-1204. PubMed ID: 31768922
[TBL] [Abstract][Full Text] [Related]
8. A quantitative study of the cell-type specific modulation of c-Rel by hydrogen peroxide and TNF-α.
Oliveira-Marques V; Silva T; Cunha F; Covas G; Marinho HS; Antunes F; Cyrne L
Redox Biol; 2013; 1(1):347-52. PubMed ID: 24024170
[TBL] [Abstract][Full Text] [Related]
9. Phosphatidylinositol 3-kinase and NF-kappa B/Rel are at the divergence of CD40-mediated proliferation and survival pathways.
Andjelic S; Hsia C; Suzuki H; Kadowaki T; Koyasu S; Liou HC
J Immunol; 2000 Oct; 165(7):3860-7. PubMed ID: 11034392
[TBL] [Abstract][Full Text] [Related]
10. Rapamycin inhibits doxorubicin-induced NF-kappaB/Rel nuclear activity and enhances the apoptosis of melanoma cells.
Romano MF; Avellino R; Petrella A; Bisogni R; Romano S; Venuta S
Eur J Cancer; 2004 Dec; 40(18):2829-36. PubMed ID: 15571967
[TBL] [Abstract][Full Text] [Related]
11. c-Rel in Epidermal Homeostasis: A Spotlight on c-Rel in Cell Cycle Regulation.
Lorenz VN; Schön MP; Seitz CS
J Invest Dermatol; 2016 Jun; 136(6):1090-1096. PubMed ID: 27032306
[TBL] [Abstract][Full Text] [Related]
12. c-Rel is a critical mediator of NF-κB-dependent TRAIL resistance of pancreatic cancer cells.
Geismann C; Grohmann F; Sebens S; Wirths G; Dreher A; Häsler R; Rosenstiel P; Hauser C; Egberts JH; Trauzold A; Schneider G; Sipos B; Zeissig S; Schreiber S; Schäfer H; Arlt A
Cell Death Dis; 2014 Oct; 5(10):e1455. PubMed ID: 25299780
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the IL-21 gene by the NF-κB transcription factor c-Rel.
Chen G; Hardy K; Bunting K; Daley S; Ma L; Shannon MF
J Immunol; 2010 Aug; 185(4):2350-9. PubMed ID: 20639489
[TBL] [Abstract][Full Text] [Related]
14. 7,12-dimethylbenz(a)anthracene treatment of a c-rel mouse mammary tumor cell line induces epithelial to mesenchymal transition via activation of nuclear factor-kappaB.
Shin SR; Sánchez-Velar N; Sherr DH; Sonenshein GE
Cancer Res; 2006 Mar; 66(5):2570-5. PubMed ID: 16510574
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma.
Li L; Xu-Monette ZY; Ok CY; Tzankov A; Manyam GC; Sun R; Visco C; Zhang M; Montes-Moreno S; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Møller MB; Wang J; Parsons BM; Winter JN; Piris MA; Pham LV; Medeiros LJ; Young KH
Oncotarget; 2015 Sep; 6(27):23157-80. PubMed ID: 26324762
[TBL] [Abstract][Full Text] [Related]
16. The inhibitory effects of transforming growth factor beta1 on breast cancer cell proliferation are mediated through regulation of aberrant nuclear factor-kappaB/Rel expression.
Sovak MA; Arsura M; Zanieski G; Kavanagh KT; Sonenshein GE
Cell Growth Differ; 1999 Aug; 10(8):537-44. PubMed ID: 10470853
[TBL] [Abstract][Full Text] [Related]
17. Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel.
Gilmore TD; Cormier C; Jean-Jacques J; Gapuzan ME
Oncogene; 2001 Oct; 20(48):7098-103. PubMed ID: 11704834
[TBL] [Abstract][Full Text] [Related]
18. c-Rel Promotes Invasion of Choriocarcinoma Cells via PI3K/AKT Signaling.
Sekiya Y; Yamamoto E; Niimi K; Nishino K; Nakamura K; Kotani T; Kajiyama H; Shibata K; Kikkawa F
Oncology; 2017; 92(5):299-310. PubMed ID: 28259870
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of an activated REL mutant enhances the transformed state of the human B-lymphoma BJAB cell line and alters its gene expression profile.
Chin M; Herscovitch M; Zhang N; Waxman DJ; Gilmore TD
Oncogene; 2009 May; 28(20):2100-11. PubMed ID: 19377508
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide analysis of gene expression in T cells to identify targets of the NF-kappa B transcription factor c-Rel.
Bunting K; Rao S; Hardy K; Woltring D; Denyer GS; Wang J; Gerondakis S; Shannon MF
J Immunol; 2007 Jun; 178(11):7097-109. PubMed ID: 17513759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
